Copyright
©The Author(s) 2023.
World J Gastroenterol. Nov 7, 2023; 29(41): 5668-5682
Published online Nov 7, 2023. doi: 10.3748/wjg.v29.i41.5668
Published online Nov 7, 2023. doi: 10.3748/wjg.v29.i41.5668
PA variable | n (%) | PA active (Met min/wk) | PA inactive (Met min/wk) | P value1 |
PRO-2 CD | n = 92 | n = 53 | n = 39 | |
Remission | 27 (29.3%) | 1353 (1026.5-2064) | 210.75 (101.25-313.75) | 0.303 |
Mild | 24 (26.1%) | 1213.65 (1039.52-1534.75) | 346.25 (229.62-566.37) | |
Moderate | 41 (44.6%) | 1240.75 (879.67-1950) | 352.5 (45-468.75) | |
Overall | 92 (100%) | 1234 (981.75-1769.25) | 280 (157.5-465) | |
PRO-2 UC | n = 127 | n = 72 | n = 55 | |
Remission | 74 (58.3%) | 1345.35 (1057.5-1766.75) | 321.25 (204.25-535.87) | 0.994 |
Active | 53 (41.7%) | 1457 (952-1964.75) | 350 (0-574) | |
Overall | 127 (100%) | 1373.35 (990-1792.62) | 325 (111.5-538.5) |
- Citation: Gravina AG, Pellegrino R, Durante T, Palladino G, D’Onofrio R, Mammone S, Arboretto G, Auletta S, Imperio G, Ventura A, Romeo M, Federico A. Inflammatory bowel diseases patients suffer from significant low levels and barriers to physical activity: The “BE-FIT-IBD” study. World J Gastroenterol 2023; 29(41): 5668-5682
- URL: https://www.wjgnet.com/1007-9327/full/v29/i41/5668.htm
- DOI: https://dx.doi.org/10.3748/wjg.v29.i41.5668